[1] Schulz M, Trebicka J. Acute-on-chronic liver failure: a global disease[J]. Gut, 2022, 71(1):5-6.
[2] Mezzano G, Juanola A, Cardenas A, et al. Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis[J]. Gut, 2022, 71(1):148-155.
[3] Moreau R, Gao B, Papp M, et al. Acute-on-chronic liver failure: a distinct clinical syndrome[J]. J Hepatol, 2021, 75(Suppl 1):S27-S35.
[4] 李珊珊,徐曼曼,杨雪,等. 2012至2021年北京佑安医院HBV相关慢加急性肝衰竭患者住院费用分析[J].肝脏,2023,28(4):405-409.
[5] Kramer L, Jordan B, Druml W, et al. Incidence and prognosis of early hepatic dysfunction in critically ill patients-a prospective multicenter study[J]. Crit Care Med, 2007, 35(4):1099-1104.
[6] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版)[J].中华肝脏病杂志,2019,27(1):18-26.
[7] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2022年版) [J].传染病信息,2023,36(1):1-17.
[8] 中华医学会肝病学分会.肝硬化腹水及相关并发症的诊疗指南[J].中华肝脏病杂志, 2017, 25(9): 664-677.
[9] Singer M, Deutschman C S, Seymour C W, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) [J]. JAMA, 2016, 315(8):801-810.
[10] Vincent J L, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine[J]. Intensive Care Med, 1996, 22(7):707-710.
[11] Vincent J L, de Mendonça A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on ‘sepsis-related problems' of the European Society of Intensive Care Medicine[J]. Crit Care Med, 1998, 26(11):1793-1800.
[12] 中国医疗保健国际交流促进会急诊医学分会,中华医学会急诊医学分会,中国医师协会急诊医师分会,等.中国脓毒症早期预防与阻断急诊专家共识[J].中国急救医学,2020,40(7):577-588.
[13] 中国医药教育协会感染疾病专业委员会.感染相关生物标志物临床意义解读专家共识[J].中华结核和呼吸杂志,2017,40(4):243-257.
[14] Wrodycki W. Usefulness of plasma procalcitonin (PCT) estimation to diagnose patients in departments of infectious diseases[J]. Przegl Epidemiol, 2003, 57(1):211-219.
[15] 《中华传染病杂志》编辑委员会.中国宏基因组学第二代测序技术检测感染病原体的临床应用专家共识[J].中华传染病杂志,2020,38(11):681-689.
[16] 王宇,许祥,童晶晶,等. 肝衰竭患者并发真菌感染病原学及影响因素[J].中华医院感染学杂志,2020,30(14):2105-2109.
[17] Jindal A, Kumar M, Sarin S K. Management of acute hepatitis B and reactivation of hepatitis B[J]. Liver Int, 2013, 33(Suppl 1):164-175.
[18] Sun L J, Yu J W, Zhao Y H, et al. Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure[J]. J Gastroenterol Hepatol, 2010, 25(3):583-590.
[19] Zhu Y, Li H, Wang X, et al. Hepatitis B virus reactivation increased the risk of developing hepatic failure and mortality in cirrhosis with acute exacerbation[J]. Front Microbiol, 2022,13:910549.
[20] 中华医学会肝病学分会重型肝病与人工肝学组.人工肝血液净化技术临床应用专家共识(2022年版)[J].临床肝胆病杂志,2022,38(4):767-775. |
